标题
Ocular Toxicity of Targeted Therapies
作者
关键词
-
出版物
JOURNAL OF CLINICAL ONCOLOGY
Volume 30, Issue 26, Pages 3277-3286
出版商
American Society of Clinical Oncology (ASCO)
发表日期
2012-05-30
DOI
10.1200/jco.2011.41.5851
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Phase I pharmacokinetic and pharmacodynamic evaluation of the vascular disrupting agent OXi4503 in patients with advanced solid tumors.
- (2017) M. Zweifel et al. JOURNAL OF CLINICAL ONCOLOGY
- AUY922, a novel HSP90 inhibitor: Final results of a first-in-human study in patients with advanced solid malignancies.
- (2017) T. A. Samuel et al. JOURNAL OF CLINICAL ONCOLOGY
- First-in-human phase I safety, pharmacokinetic (PK), and pharmacodynamic (PD) analysis of the oral MEK-inhibitor AS703026 (two regimens [R]) in patients (pts) with advanced solid tumors.
- (2017) J. Delord et al. JOURNAL OF CLINICAL ONCOLOGY
- Safety and efficacy results from the first-in-human study of the oral MEK 1/2 inhibitor GSK1120212.
- (2017) J. R. Infante et al. JOURNAL OF CLINICAL ONCOLOGY
- First-in-human, safety, pharmacodynamic (PD) and pharmacokinetic (PK) trial of a first-in-class dual RAF/MEK inhibitor, RO5126766, in patients with advanced or metastatic solid tumors.
- (2017) S. O. Dolly et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase I (Ph) safety, pharmacodynamic (PD), and pharmacokinetic (PK) trial of a pure MEK inhibitor (i), RO4987655, in patients with advanced /metastatic solid tumor.
- (2017) S. Leijen et al. JOURNAL OF CLINICAL ONCOLOGY
- Safety and evidence of activity of MSC1936369, an oral MEK1/2 inhibitor, in patients with advanced malignancies.
- (2017) N. Houede et al. JOURNAL OF CLINICAL ONCOLOGY
- Targeted Therapies for Renal Cell Carcinoma: Review of Adverse Event Management Strategies
- (2012) T. Eisen et al. JNCI-Journal of the National Cancer Institute
- The Expanding Role of Vascular Endothelial Growth Factor Inhibitors in Ophthalmology
- (2012) Michael W. Stewart MAYO CLINIC PROCEEDINGS
- Beyond VEGF: Inhibition of the Fibroblast Growth Factor Pathway and Antiangiogenesis
- (2011) C. Lieu et al. CLINICAL CANCER RESEARCH
- Phase 2 trial of linifanib (ABT-869) in patients with advanced renal cell cancer after sunitinib failure
- (2011) Nizar M. Tannir et al. EUROPEAN JOURNAL OF CANCER
- Neurosensory retinal detachment due to sunitinib treatment
- (2011) A Wegner et al. EYE
- Trichomegaly and Poliosis of the Eyelashes During Cetuximab Treatment of Metastatic Colorectal Cancer
- (2011) Nelson A. Rodriguez et al. JOURNAL OF CLINICAL ONCOLOGY
- Activity of XL184 (Cabozantinib), an Oral Tyrosine Kinase Inhibitor, in Patients With Medullary Thyroid Cancer
- (2011) Razelle Kurzrock et al. JOURNAL OF CLINICAL ONCOLOGY
- First-in-Man Clinical Trial of the Oral Pan-AKT Inhibitor MK-2206 in Patients With Advanced Solid Tumors
- (2011) Timothy A. Yap et al. JOURNAL OF CLINICAL ONCOLOGY
- Comparative effectiveness of axitinib versus sorafenib in advanced renal cell carcinoma (AXIS): a randomised phase 3 trial
- (2011) Brian I Rini et al. LANCET
- Crizotinib in Anaplastic Large-Cell Lymphoma
- (2011) Carlo Gambacorti-Passerini et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy of Intravitreal Bevacizumab for Stage 3+ Retinopathy of Prematurity
- (2011) Helen A. Mintz-Hittner et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ranibizumab and Bevacizumab for Neovascular Age-Related Macular Degeneration
- (2011) NEW ENGLAND JOURNAL OF MEDICINE
- Sunitinib Malate for the Treatment of Pancreatic Neuroendocrine Tumors
- (2011) Eric Raymond et al. NEW ENGLAND JOURNAL OF MEDICINE
- Drug-Induced Graves Disease From CTLA-4 Receptor Suppression
- (2011) Gary Borodic et al. OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY
- Acute intraocular inflammation following intravitreal injection of bevacizumab - a large cluster of cases
- (2010) Michael Fielden et al. ACTA OPHTHALMOLOGICA
- Cetuximab-Associated Elongation of the Eyelashes
- (2010) Philip R. Cohen et al. AMERICAN JOURNAL OF CLINICAL DERMATOLOGY
- Phase I Pharmacokinetic and Pharmacodynamic Study of the Oral MAPK/ERK Kinase Inhibitor PD-0325901 in Patients with Advanced Cancers
- (2010) P. M. LoRusso et al. CLINICAL CANCER RESEARCH
- The First-in-Human Study of the Hydrogen Sulfate (Hyd-Sulfate) Capsule of the MEK1/2 Inhibitor AZD6244 (ARRY-142886): A Phase I Open-Label Multicenter Trial in Patients with Advanced Cancer
- (2010) U. Banerji et al. CLINICAL CANCER RESEARCH
- Central serous chorioretinopathy: an update on pathogenesis and treatment
- (2010) M Gemenetzi et al. EYE
- Regorafenib (BAY 73-4506): A new oral multikinase inhibitor of angiogenic, stromal and oncogenic receptor tyrosine kinases with potent preclinical antitumor activity
- (2010) Scott M. Wilhelm et al. INTERNATIONAL JOURNAL OF CANCER
- AIDS-Related Kaposi's Sarcoma of the Gastrointestinal Tract
- (2010) Steven Attia et al. JOURNAL OF CLINICAL ONCOLOGY
- Pazopanib in Locally Advanced or Metastatic Renal Cell Carcinoma: Results of a Randomized Phase III Trial
- (2010) Cora N. Sternberg et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II Study of the Antibody Drug Conjugate Trastuzumab-DM1 for the Treatment of Human Epidermal Growth Factor Receptor 2 (HER2) –Positive Breast Cancer After Prior HER2-Directed Therapy
- (2010) Howard A. Burris et al. JOURNAL OF CLINICAL ONCOLOGY
- From basic research to clinical development of MEK1/2 inhibitors for cancer therapy
- (2010) Christophe Frémin et al. Journal of Hematology & Oncology
- Cetuximab-induced hypertrichosis of the scalp and eyelashes
- (2010) Sergio Vano-Galvan et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Management of adverse events associated with tyrosine kinase inhibitors in the treatment of chronic myeloid leukemia
- (2010) E Jabbour et al. LEUKEMIA
- Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer
- (2010) Eunice L. Kwak et al. NEW ENGLAND JOURNAL OF MEDICINE
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
- (2010) F. Stephen Hodi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Retinal and Ocular Toxicity in Ocular Application of Drugs and Chemicals – Part II: Retinal Toxicity of Current and New Drugs
- (2010) Fernando Marcondes Penha et al. OPHTHALMIC RESEARCH
- A Prospective Randomized Trial of Intravitreal Bevacizumab or Laser Therapy in the Management of Diabetic Macular Edema (BOLT Study)
- (2010) Michel Michaelides et al. OPHTHALMOLOGY
- Trichomegaly of the Eyelashes After Colorectal Cancer Treatment With the Epidermal Growth Factor Receptor Inhibitor Cetuximab
- (2009) Richard Bambury et al. Clinical Colorectal Cancer
- Persistent Corneal Epithelial Defect Associated With Erlotinib Treatment
- (2009) Keegan S Johnson et al. CORNEA
- Erlotinib-induced trichomegaly in a male patient with pancreatic cancer
- (2009) Muhammad Wasif Saif et al. Cutaneous and Ocular Toxicology
- Ocular Side Effects Associated with Imatinib Mesylate and Perifosine for Gastrointestinal Stromal Tumor
- (2009) S. Serdar Dogan et al. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- A case of trichomegaly of the eyelashes and facial hypertrichosis induced by erlotinib (Tarceva®)
- (2009) Gemma Márquez et al. INTERNATIONAL JOURNAL OF DERMATOLOGY
- Phase I Study of the Humanized Anti-CD40 Monoclonal Antibody Dacetuzumab in Refractory or Recurrent Non-Hodgkin's Lymphoma
- (2009) Ranjana Advani et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase I Study of Intravenous Vascular Endothelial Growth Factor Trap, Aflibercept, in Patients With Advanced Solid Tumors
- (2009) A. Craig Lockhart et al. JOURNAL OF CLINICAL ONCOLOGY
- PD0325901, a Mitogen-Activated Protein Kinase Kinase Inhibitor, Produces Ocular Toxicity in a Rabbit Animal Model of Retinal Vein Occlusion
- (2009) Wenhu Huang et al. JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS
- Anterior Uveitis Complicating Zoledronic Acid Infusion
- (2009) Annalisa Colucci et al. OCULAR IMMUNOLOGY AND INFLAMMATION
- Characteristics of severe intraocular inflammation following intravitreal injection of bevacizumab (Avastin)
- (2008) M Georgopoulos et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Trichomegaly of the eyelashes following treatment with cetuximab
- (2008) M. Vaccaro et al. CLINICAL AND EXPERIMENTAL DERMATOLOGY
- U.S. Food and Drug Administration Approval: Panitumumab for Epidermal Growth Factor Receptor-Expressing Metastatic Colorectal Carcinoma with Progression Following Fluoropyrimidine-, Oxaliplatin-, and Irinotecan-Containing Chemotherapy Regimens
- (2008) R. M. Giusti et al. CLINICAL CANCER RESEARCH
- Association of the CTLA-4 gene with Vogt–Koyanagi–Harada syndrome
- (2008) Liping Du et al. CLINICAL IMMUNOLOGY
- Persisting Corneal Erosion Under Cetuximab (Erbitux) Treatment (Epidermal Growth Factor Receptor Antibody)
- (2008) Claudia G Foerster et al. CORNEA
- Trichomegaly of the Eyelashes After Lung Cancer Treatment with the Epidermal Growth Factor Receptor Inhibitor Erlotinib
- (2008) Fadi Braiteh et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase I Pharmacokinetic and Pharmacodynamic Study of the Oral, Small-Molecule Mitogen-Activated Protein Kinase Kinase 1/2 Inhibitor AZD6244 (ARRY-142886) in Patients With Advanced Cancers
- (2008) Alex A. Adjei et al. JOURNAL OF CLINICAL ONCOLOGY
- Unilateral Anterior Uveitis Complicating Zoledronic Acid Therapy in Prostate Cancer
- (2008) FRÉDÉRIC BANAL et al. JOURNAL OF RHEUMATOLOGY
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ulcerative Keratitis in Gastrointestinal Stromal Tumor Patients Treated with Perifosine
- (2008) Debraj Shome et al. OPHTHALMOLOGY
- Posterior reversible encephalopathy syndrome during sunitinib therapy
- (2008) R. Cumurciuc et al. REVUE NEUROLOGIQUE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started